Drug Manufacturers - General · NYSE
Preço Atual
$228.84
MOAT COMPETITIVO
↑Pharmaceutical Patent Protection
J&J benefits from strong patent protection on key pharmaceutical products, creating a period of market exclusivity and high profitability. This shields them from immediate generic competition.
↑Brand Reputation and Consumer Trust
Decades of established brands like Band-Aid and Tylenol foster strong consumer trust. This brand equity allows for premium pricing and customer loyalty, even with alternatives.
↑Diversified Healthcare Portfolio
J&J's diverse segments (pharmaceuticals, medical devices, consumer health) reduce reliance on any single product or market. This diversification provides stability and resilience.
RISCOS DE INVESTIMENTO
↓Patent Expirations and Generic Competition
Loss of patent protection on blockbuster drugs exposes J&J to significant revenue declines from generic versions. This necessitates constant innovation and pipeline development.
↓Litigation and Product Liability
J&J faces ongoing litigation related to product safety and marketing practices. These lawsuits can result in substantial financial penalties and reputational damage.
↓Regulatory Scrutiny and Pricing Pressure
Increased regulatory scrutiny and government efforts to control drug prices could negatively impact J&J's profitability. This is a constant challenge in the healthcare industry.
Combine insights de IA com valuation DCF ou PE para calcular o valor intrínseco. Tome decisões melhores baseadas em dados.
Esta página fornece insights de valuation com IA para Johnson & Johnson (JNJ), incluindo moat competitivo e fatores de risco de investimento. O valuation é central para decisões de investimento sólidas — use as ferramentas de valuation DCF e PE do MiniValuator junto com estes insights de IA para calcular o valor intrínseco de JNJ, margem de segurança, e chegar a um valuation bem fundamentado.
